Business ❯ Healthcare ❯ Pharmaceuticals

Drug Approval

Wegovy New Drug Application Everolimus Tablets Cardiovascular Benefits Semaglutide Injection FDA Approval FDA Regulations Market Withdrawal Cobenfy Palsonify Eli Lilly Weight Loss Medications Regulatory Compliance

FDA Approves Novo Nordisk’s Wegovy Pill, First Oral GLP-1

Out-of-pocket buyers will have access through TrumpRx at the same $149 monthly price.

Savara Investors Pressed to Meet Class-Action Deadlines Over Alleged MOLBREEVI BLA Deficiencies

Crinetics Wins FDA Approval for Oral Acromegaly Drug Palsonify as JMP Lifts Price Target

Cytokinetics Hit With Securities Class Action Over Aficamten Timeline Disclosures

EMA Approves Cardiovascular Indication for Novo Nordisk’s Rybelsus